EUVIMEDEUVIMED entdecken
Crossref

Novel Mixed-Ligand Ruthenium(III) Complexes Incorporating 2-Aminomethylbenzimidazole: Synthesis, Structural Characterization, and Biological Evaluation

KIRTI VARDHAN GAUTAM, RAKESH KUMAR RANJAN, SHEO SHANKAR KUMAR, UTKARSH DEEPANKAR

Journal of Ultra Chemistry · 28.10.2026 · 22 (4) · 77-91

DOI: 10.22147/juc/220403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ultra Chemistry, online erschienen am 28.10.2026. Verfasst von KIRTI VARDHAN GAUTAM und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of three new halide-free ruthenium (III) complexes was synthesized using 2-aminomethylbenzimidazole as the principal chelating ligand in combination with different auxiliary ligand systems. Their compositions and coordination behavior were investigated through elemental analysis, conductivity measurements, UV-Visible spectroscopy, magnetic susceptibility studies, FT-IR spectroscopy, and low-temperature EPR spectroscopy. The overall experimental findings support the formation of mononuclear Ru(III) complexes exhibiting 1:1 electrolyte behavior and a low-spin d5 Ru(III) center adopting a distorted octahedral coordination geometry. The interactions of the synthesized complexes with biological macromolecules were examined by employing absorption and fluorescence titration methods. The findings obtained from DNAbinding experiments showed that the complex with the aromatic diimine ligand presented the highest affinity toward calf thymus DNA, in agreement with a partial intercalative mode of association. Fluorescence quenching studies with Bovine Serum Albumin (BSA) indicated the formation of stable protein–complex adducts predominantly through a static quenching mechanism. The antiproliferative activities of the complexes were examined against HeLa and MCF-7 cell lines, revealing a concentration-dependent inhibition of cell growth. These observations underline the importance of ligand architecture in controlling biological activity, making these complexes attractive candidates for targeted metallodrug design

Zitieren

APA

GAUTAM, K. V., RANJAN, R. K., KUMAR, S. S., & DEEPANKAR, U. (2026). Novel Mixed-Ligand Ruthenium(III) Complexes Incorporating 2-Aminomethylbenzimidazole: Synthesis, Structural Characterization, and Biological Evaluation. Journal of Ultra Chemistry, 22(4), 77-91. https://doi.org/10.22147/juc/220403

Vancouver

GAUTAM KV, RANJAN RK, KUMAR SS, DEEPANKAR U. Novel Mixed-Ligand Ruthenium(III) Complexes Incorporating 2-Aminomethylbenzimidazole: Synthesis, Structural Characterization, and Biological Evaluation. Journal of Ultra Chemistry. 2026;22(4):77-91. doi:10.22147/juc/220403

BibTeX
@article{GAUTAM2026,
  author = {GAUTAM, KIRTI VARDHAN and RANJAN, RAKESH KUMAR and KUMAR, SHEO SHANKAR and DEEPANKAR, UTKARSH},
  title = {Novel Mixed-Ligand Ruthenium(III) Complexes Incorporating 2-Aminomethylbenzimidazole: Synthesis, Structural Characterization, and Biological Evaluation},
  journal = {Journal of Ultra Chemistry},
  year = {2026},
  volume = {22},
  number = {4},
  pages = {77--91},
  doi = {10.22147/juc/220403}
}
Kostenlos starten →